参考文献/References:
[1] Khawli LA,Biela B,Hu P,et al.Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors[J].Hybrid Hybridomics,2003,22(1):1-9.
[2] Hirayama K,Chung YS,Sawada T,et al.Characterization and biodistribution of a mouse/human chimeric antibody directed against pancreatic cancer mucin[J].Cancer,1995,75(6 Suppl):1545-1553.
[3] Van de Wiele C,Revets H,Mertens N.Radioimmunoimaging.Advances and prospects[J].Q J Nucl Med Mol Imaging,2004,48(4):317-325.
[4] Vollmers HP,Brandlein S.Nature’s best weapons to fight cancer.Revival of human monoclonal IgM antibodies[J].Hum Antibodies,2002,11(4):131-142.
[5] Bruggemann M.Human antibody expression in transgenic mice[J].Arch Immunol Ther Exp (Warsz),2001,49(3):203-208.
[6] Lantto J,Jirholt P,Barrios Y,et al.Chain shuffling to modify properties of recombinant immunoglobulins[J].Methods Mol Biol,2002,178:303-316.
[7] Ghetie V,Ward ES.Transcytosis and catabolism of antibody[J].Immunol Res,2002,25(2):97-113.
[8] Janeway CA Jr,Travers P,Walport M,et al.Immunobiology 5[M].New York:Garland Publishing,2001.
[9] Ober R J,Martinez C,Lai X,et al.Exocytosis of IgG as mediated by the receptor,FcRn:an analysis at the single-molecule level[J].Proc Natl Acad Sci USA,2004,101(30):11076-11081.
[10] Otsuji E,Matsumura H,Okamoto K,et al.Application of 99mTc-labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma[J].J Surg Oncol,2003,84(3):160-165.
[11] 段红.单链抗体及其在肿瘤免疫上的应用[J].国际肿瘤学杂志,2006,33(7):487-489.
[12] Kortt AA,Dolezal O,Power BE,et al.Dimeric and trimeric antibodies:high avidity scFvs for cancer targeting[J].Biomol Eng,2001,18(3):95-108.
[13] Wu AM,Yazaki PJ.Designer genes:recombinant antibody fragments for biological imaging[J].Q J Nucl Med,2000,44(3):268-283.
[14] Holt LJ,Herring C,Jespers IS,et al.Domain antibodies:proteins for therapy[J].Trends Biotechnol,2003,21(11):484-490.
[15] Cortez-Retamozo V,Lauwereys M,Hassanzadeh Gh G,et al.Efficient tumor targeting by single-domain antibody fragments of camels[J].Int J Cancer,2002,98(3):456-462.
[16] Caliceti P,Chinol M,Roldo M,et al.Poly (ethylene glycol)-avidin bioconjugates:suitable candidates for tumor pretargeting[J].J Control Release,2002,83(1):97-108.
[17] Cardillo TM,Karacay I-I,Goldenberg DM,et al.Improved targeting of pancreatic cancer:experimental studies of a new bispecific antibody,pretargeting enhancement system for immunoscintigraphy[J].Clin Cancer Res,2004,10(10):3552-3561.
[18] 陈士伟,郭建生,颜怀军,等.双特异性抗体治疗卵巢癌的研究进展[J].中国实用妇科与产科杂志,2006,22(4):309-312.
[19] La Valle GJ,Martinez DA,Sobel D,et al.Assessment of disseminated pancreatic cancer:a comparison of traditional exploratory laparotomy and radioimmunoguided surgery[J].Surgery,1997,122(5):867-871.
相似文献/References:
[1]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[2]李詝,朱朝晖,李方.蛋白激酶小分子抑制剂PET显像研究进展及其在胰腺癌诊断中的应用前景[J].国际放射医学核医学杂志,2015,39(1):45.[doi:10.3760/cma.j.issn.1673-4114.2015.01.010]
Li Zhu,Zhu Zhaohui,Li Fang.Advances of small-molecule protein kinase inhibitor-based PET tracers with prospective application in pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):45.[doi:10.3760/cma.j.issn.1673-4114.2015.01.010]
[3]吴冰,石洪成.18F-FDG PET-CT在胰腺癌诊治中的应用[J].国际放射医学核医学杂志,2011,35(4):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]
WU Bing,SHI Hong-cheng.18F-FDG PET-CT for the clinical application of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]
[4]邓胜明,张玮,章斌,等.188Re-胰岛素样生长因子1类似物在荷人胰腺癌裸鼠体内分布及其显像研究[J].国际放射医学核医学杂志,2008,32(3):129.
DENG Sheng-ming,ZHANG Wei,ZHANG Bin,et al.Studies on biodistribution and imaging of 188Re labeled insulin-like growth factor-1 analogue in nude mice bearing human pancreatic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):129.
[5]姜炜,郭阳,徐玲,等.立体定向放射治疗胰腺癌[J].国际放射医学核医学杂志,2007,31(1):55.
JIANG Wei,GUO Yang,XU Ling,et al.Stereotactic radiotherapy for pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):55.
[6]刘军叶,郭鹞,郭国祯.乏氧靶向性自杀基因治疗系统增强胰腺癌放疗效果的实验研究[J].国际放射医学核医学杂志,2006,30(3):168.
LIU Jun-ye,GUO Yao,GUO Guo-zhen.Hypoxia-targeted suicidal gene therapy system enhances antitumor effects of radiotherapy on pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):168.
[7]王济东,王俊杰.胰腺癌组织间近距离放射治疗的研究进展[J].国际放射医学核医学杂志,2006,30(3):182.
WANG Ji-dong,WANG Jun-jie.Evolution of interstitial brachytherapy for pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):182.
[8]薛艳,安瑞芳.放射免疫显像在妇科肿瘤中的研究与应用[J].国际放射医学核医学杂志,2006,30(1):36.
XUE Yan,AN Rui-fang.A research on radioimmunoimaging and its application in diagnosis of gynecological tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):36.
[9]白静,王俊杰.125I粒子组织间植入治疗局部晚期胰腺癌进展[J].国际放射医学核医学杂志,2006,30(2):127.
BAI Jing,WANG Jun-jie.Advances in the therapy of pancreatic carcinoma with 125I seeds[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):127.
[10]管梁,吕中伟.18F-FDG PET显像在鉴别胰腺良恶性肿块中的应用价值[J].国际放射医学核医学杂志,2000,24(6):259.
GUAN Liang,LU Zhongwei.The application value of 18-fluorine fluorodeoxyglucose positron emission tomographic imaging in the differential diagnosis of benign and malignant pancreatic tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(5):259.